Across TCGA pan-cancer cohorts, WRAP53 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated WRAP53 data layer compared with 29 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher WRAP53 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WRAP53 expression acts as an unfavorable survival marker.
UCEC are the cancer types where WRAP53 Mutation most reproducibly stratifies survival.